$CHD
CHURCH & DWIGHT CO INC /DE/

2023 Q2 Form 10-Q Financial Statement

#000095017023015179 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $1.454B $1.430B $1.297B
YoY Change 9.74% 10.22% 4.71%
Cost Of Revenue $815.3M $807.8M $744.7M
YoY Change 4.55% 8.47% 8.24%
Gross Profit $638.9M $622.0M $552.5M
YoY Change 17.16% 12.58% 0.29%
Gross Profit Margin 43.93% 43.5% 42.59%
Selling, General & Admin $315.1M $207.8M $169.9M
YoY Change 74.28% 22.31% 13.57%
% of Gross Profit 49.32% 33.41% 30.75%
Research & Development $30.20M $26.70M $24.50M
YoY Change 11.03% 8.98% 1.66%
% of Gross Profit 4.73% 4.29% 4.43%
Depreciation & Amortization $55.80M $16.90M $16.60M
YoY Change 232.14% 1.81% -1.19%
% of Gross Profit 8.73% 2.72% 3.0%
Operating Expenses $345.3M $234.5M $194.4M
YoY Change 66.01% 20.63% 11.92%
Operating Profit $293.6M $291.9M $280.7M
YoY Change 12.23% 3.99% -7.24%
Interest Expense -$25.90M $28.80M $16.60M
YoY Change -234.2% 73.49% 18.57%
% of Operating Profit -8.82% 9.87% 5.91%
Other Income/Expense, Net $1.700M $1.300M -$300.0K
YoY Change -533.33% 200.0%
Pretax Income $269.4M $268.8M $266.2M
YoY Change 9.29% 0.98% -8.52%
Income Tax $48.20M $65.60M $61.80M
% Of Pretax Income 17.89% 24.4% 23.22%
Net Earnings $221.2M $203.2M $204.4M
YoY Change 18.23% -0.59% -7.39%
Net Earnings / Revenue 15.21% 14.21% 15.76%
Basic Earnings Per Share $0.90 $0.83 $0.84
Diluted Earnings Per Share $0.89 $0.82 $0.83
COMMON SHARES
Basic Shares Outstanding 244.3M 244.0M 242.6M
Diluted Shares Outstanding 247.9M 246.8M 246.7M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $396.9M $202.8M $174.4M
YoY Change -37.96% 16.28% 36.78%
Cash & Equivalents $396.9M $202.8M $174.4M
Short-Term Investments
Other Short-Term Assets $43.20M $49.50M $41.50M
YoY Change 2.37% 19.28% 11.56%
Inventory $675.4M $653.3M $598.8M
Prepaid Expenses
Receivables $460.9M $429.3M $407.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.576B $1.335B $1.222B
YoY Change -9.96% 9.26% 9.89%
LONG-TERM ASSETS
Property, Plant & Equipment $958.7M $772.2M $653.2M
YoY Change 45.13% 18.22% 6.78%
Goodwill $2.430B $2.430B $2.274B
YoY Change 7.03% 6.88% 1.98%
Intangibles $3.370B $3.401B $3.465B
YoY Change -1.89% -1.85% 12.51%
Long-Term Investments $14.70M $13.80M $10.80M
YoY Change 20.49% 27.78% 9.09%
Other Assets $161.1M $314.8M $316.9M
YoY Change -49.02% -0.66% -6.38%
Total Long-Term Assets $6.935B $6.932B $6.719B
YoY Change 3.59% 3.16% 7.18%
TOTAL ASSETS
Total Short-Term Assets $1.576B $1.335B $1.222B
Total Long-Term Assets $6.935B $6.932B $6.719B
Total Assets $8.511B $8.267B $7.941B
YoY Change 0.78% 4.1% 7.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $677.7M $651.5M $655.0M
YoY Change 1.57% -0.53% 19.68%
Accrued Expenses $432.4M $398.3M $354.2M
YoY Change 23.83% 12.45% 18.42%
Deferred Revenue
YoY Change
Short-Term Debt $4.000M $18.70M $103.0M
YoY Change 21.21% -81.84% -63.5%
Long-Term Debt Due $699.7M
YoY Change
Total Short-Term Liabilities $1.122B $1.127B $1.872B
YoY Change -35.04% -39.79% 46.87%
LONG-TERM LIABILITIES
Long-Term Debt $2.401B $2.400B $1.611B
YoY Change 14.12% 48.96% -11.14%
Other Long-Term Liabilities $323.3M $274.1M $283.5M
YoY Change 15.96% -3.32% -16.57%
Total Long-Term Liabilities $2.724B $2.674B $1.895B
YoY Change 14.33% 41.14% -11.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.122B $1.127B $1.872B
Total Long-Term Liabilities $2.724B $2.674B $1.895B
Total Liabilities $4.600B $4.599B $4.538B
YoY Change -5.94% 1.34% 8.84%
SHAREHOLDERS EQUITY
Retained Earnings $5.815B $5.661B $5.507B
YoY Change 3.29% 2.81% 11.36%
Common Stock $716.3M $687.7M $627.0M
YoY Change 11.42% 9.68% 4.67%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.593B $2.655B $2.678B
YoY Change -2.95% -0.84% 17.54%
Treasury Stock Shares $49.52M $50.17M
Shareholders Equity $3.911B $3.668B $3.403B
YoY Change
Total Liabilities & Shareholders Equity $8.511B $8.267B $7.941B
YoY Change 0.78% 4.1% 7.59%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $221.2M $203.2M $204.4M
YoY Change 18.23% -0.59% -7.39%
Depreciation, Depletion And Amortization $55.80M $16.90M $16.60M
YoY Change 232.14% 1.81% -1.19%
Cash From Operating Activities $236.1M $273.1M $152.8M
YoY Change 49.81% 78.73% 52.5%
INVESTING ACTIVITIES
Capital Expenditures $38.20M $25.00M $15.60M
YoY Change -264.66% 60.26% -40.68%
Acquisitions
YoY Change
Other Investing Activities -$1.400M $4.600M $100.0K
YoY Change 55.56% 4500.0% -97.3%
Cash From Investing Activities -$39.60M -$29.60M -$15.70M
YoY Change 64.32% 88.54% -47.67%
FINANCING ACTIVITIES
Cash Dividend Paid $66.30M $63.70M
YoY Change 4.08% 2.91%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $100.0M $0.00
YoY Change
Cash From Financing Activities -3.700M -311.7M -202.6M
YoY Change -101.11% 53.85% 62.08%
NET CHANGE
Cash From Operating Activities 236.1M 273.1M 152.8M
Cash From Investing Activities -39.60M -29.60M -15.70M
Cash From Financing Activities -3.700M -311.7M -202.6M
Net Change In Cash 192.8M -67.50M -66.20M
YoY Change -58.83% 1.96% 19.06%
FREE CASH FLOW
Cash From Operating Activities $236.1M $273.1M $152.8M
Capital Expenditures $38.20M $25.00M $15.60M
Free Cash Flow $197.9M $248.1M $137.2M
YoY Change 9.46% 80.83% 85.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000313927
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-10585
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CHURCH & DWIGHT CO., INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-4996950
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
500 Charles Ewing Boulevard
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Ewing
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08628
CY2023Q1 dei City Area Code
CityAreaCode
609
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
806-1200
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $1 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
CHD
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
244263640
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1429800000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1297200000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
807800000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
744700000
CY2023Q1 us-gaap Gross Profit
GrossProfit
622000000.0
CY2022Q1 us-gaap Gross Profit
GrossProfit
552500000
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
122300000
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
101900000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
207800000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
169900000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
291900000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
280700000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4400000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2400000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1300000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-300000
CY2023Q1 us-gaap Interest Expense
InterestExpense
28800000
CY2022Q1 us-gaap Interest Expense
InterestExpense
16600000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
268800000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
266200000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65600000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61800000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
203200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
204400000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
243800000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
242600000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246800000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246700000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.27
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
203200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
204400000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2400000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2200000
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1500000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1900000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-800000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
15300000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3100000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15000000.0
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
206300000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
219400000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202800000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
270300000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3600000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3500000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
429300000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
422000000.0
CY2023Q1 us-gaap Inventory Net
InventoryNet
653300000
CY2022Q4 us-gaap Inventory Net
InventoryNet
646600000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
49500000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
57000000.0
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1334900000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1395900000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
772200000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
761100000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
13800000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12700000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3400600000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3431600000
CY2023Q1 us-gaap Goodwill
Goodwill
2430300000
CY2022Q4 us-gaap Goodwill
Goodwill
2426800000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
314800000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
317500000
CY2023Q1 us-gaap Assets
Assets
8266600000
CY2022Q4 us-gaap Assets
Assets
8345600000
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
18700000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
74000000.0
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1049800000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1102800000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
58400000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7000000.0
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1126900000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1183800000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2400100000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2599500000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
755800000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
757000000.0
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
274100000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
273400000
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
42000000.0
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
42000000.0
CY2023Q1 us-gaap Liabilities
Liabilities
4598900000
CY2022Q4 us-gaap Liabilities
Liabilities
4855700000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0.0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0.0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
293709982
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
293709982
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
293700000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
293700000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
394000000.0
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
366200000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5661200000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5524600000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26200000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29300000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
49515884
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
49814106
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2655000000.0
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2665300000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3667700000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3489900000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8266600000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8345600000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
203200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
204400000
CY2023Q1 us-gaap Depreciation
Depreciation
16900000
CY2022Q1 us-gaap Depreciation
Depreciation
16600000
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
38000000.0
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
37100000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1600000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1000000.0
CY2023Q1 chd Income Loss From Equity Method Investments Excluding Impairment Charges
IncomeLossFromEquityMethodInvestmentsExcludingImpairmentCharges
4400000
CY2022Q1 chd Income Loss From Equity Method Investments Excluding Impairment Charges
IncomeLossFromEquityMethodInvestmentsExcludingImpairmentCharges
2400000
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3300000
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
800000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25800000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2900000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000.0
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1500000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2400000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1800000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4800000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63700000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-700000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-3100000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62000000.0
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-95200000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
57700000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
57600000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1700000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4100000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
273100000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
152800000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25000000.0
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15600000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4600000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
100000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29600000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15700000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200000000.0
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0.0
CY2023Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-55600000
CY2022Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-149900000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10200000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11000000.0
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
66300000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
63700000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-311700000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-202600000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
700000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-700000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-67500000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66200000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
270300000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240600000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202800000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174400000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
21300000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
19700000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
9400000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
5200000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
16500000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13100000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3233200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
204400000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15000000.0
CY2022Q1 us-gaap Dividends Cash
DividendsCash
63700000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-0.0
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000000.0
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3402900000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3489900000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
203200000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3100000
CY2023Q1 us-gaap Dividends Cash
DividendsCash
66300000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
37800000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3667700000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26700000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24500000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11900000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
62.64
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1000000.0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
83.13
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
300000
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
44.95
CY2023Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
146300000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
149500000
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
40800000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
46800000
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
466200000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
450300000
CY2023Q1 us-gaap Inventory Net
InventoryNet
653300000
CY2022Q4 us-gaap Inventory Net
InventoryNet
646600000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1628300000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1601200000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
856100000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
840100000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
772200000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
761100000
CY2023Q1 us-gaap Depreciation
Depreciation
16900000
CY2022Q1 us-gaap Depreciation
Depreciation
16600000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
243800000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
242600000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000.0
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4100000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246800000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246700000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3900000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
100000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
81.43
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12500000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
64.43
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
300100000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7000000.0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
51.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M18D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
261800000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10700000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
16800000
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14500000
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2800000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1.0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
23.93
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q1 us-gaap Stock Issued1
StockIssued1
23700000
CY2022Q1 us-gaap Stock Issued1
StockIssued1
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.040
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y3M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.123
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.013
CY2022Q4 us-gaap Commercial Paper
CommercialPaper
70600000
CY2023Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
3700000
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
3400000
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
18700000
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2023Q1 chd Business Combination Cash Purchase Price Net Of Contingent Consideration
BusinessCombinationCashPurchasePriceNetOfContingentConsideration
546800000
CY2023Q1 chd Business Acquisition Additional Cash Payment
BusinessAcquisitionAdditionalCashPayment
8000000.0
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
61500000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
179000000.0
CY2023Q1 us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
3500000
CY2022 chd Cash Payments
CashPayments
3800000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2238300000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
799200000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1439100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2760900000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
879700000
CY2022 chd Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
-411000000.0
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1470200000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
31100000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29500000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
124000000.0
CY2023Q1 us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
411000000.0
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
46300000
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2023Q1 chd Discount On Estimated Future Cashflow
DiscountOnEstimatedFutureCashflow
0.085
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
74000000.0
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1961500000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1961400000
CY2022Q4 chd Tradename Percentage Of Fair Value In Excess Of Carrying Amount
TradenamePercentageOfFairValueInExcessOfCarryingAmount
0.46
CY2023Q1 us-gaap Goodwill
Goodwill
2430300000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
158000000.0
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162600000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21900000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21900000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
148800000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
151900000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
170700000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
173800000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y9M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y10M24D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2023Q1 us-gaap Lease Cost
LeaseCost
7700000
CY2022Q1 us-gaap Lease Cost
LeaseCost
7900000
CY2023Q1 chd Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfModifications
1000000.0
CY2022Q1 chd Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfModifications
1500000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7600000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7500000
CY2023Q1 chd Operating Lease Righ Of Use Asset Amortization
OperatingLeaseRighOfUseAssetAmortization
5900000
CY2022Q1 chd Operating Lease Righ Of Use Asset Amortization
OperatingLeaseRighOfUseAssetAmortization
6200000
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
20500000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
21000000.0
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
21900000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
28400000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
27000000.0
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
19300000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
18500000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
94800000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
209900000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
39200000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
170700000
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
651500000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
666700000
CY2023Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
211800000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
234400000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47400000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66800000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
139100000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
134900000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1049800000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1102800000
CY2023Q1 chd Supply Chain Finance Program Outstanding Obligations
SupplyChainFinanceProgramOutstandingObligations
88300000
CY2023Q1 chd Supply Chain Financing Payments Included In Operating Activities Within The Companys Consolidated Statements Of Cash Flows
SupplyChainFinancingPaymentsIncludedInOperatingActivitiesWithinTheCompanysConsolidatedStatementsOfCashFlows
103600000
CY2023Q1 us-gaap Commercial Paper
CommercialPaper
15000000.0
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2400100000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2599500000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-68200000
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
20900000
CY2022Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
400000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
5500000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15000000.0
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53200000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29300000
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
4200000
CY2023Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-900000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
200000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3100000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26200000
CY2023Q1 us-gaap Long Term Purchase Commitment Minimum Quantity Required
LongTermPurchaseCommitmentMinimumQuantityRequired
240000
CY2023Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
396700000
CY2023Q1 chd Outstanding Guarantees And Letters Of Credit
OutstandingGuaranteesAndLettersOfCredit
6300000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1429800000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1297200000

Files In Submission

Name View Source Status
0000950170-23-015179-index-headers.html Edgar Link pending
0000950170-23-015179-index.html Edgar Link pending
chd-20230331_lab.xml Edgar Link unprocessable
0000950170-23-015179.txt Edgar Link pending
0000950170-23-015179-xbrl.zip Edgar Link pending
chd-20230331.htm Edgar Link pending
chd-20230331.xsd Edgar Link pending
chd-ex31_1.htm Edgar Link pending
chd-ex31_2.htm Edgar Link pending
chd-ex32_1.htm Edgar Link pending
chd-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img11582094_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
chd-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chd-20230331_def.xml Edgar Link unprocessable
chd-20230331_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
chd-20230331_cal.xml Edgar Link unprocessable